DK1448207T3 - Doseringsplan og farmaceutisk sammensætning af nödprævention - Google Patents

Doseringsplan og farmaceutisk sammensætning af nödprævention

Info

Publication number
DK1448207T3
DK1448207T3 DK02783334T DK02783334T DK1448207T3 DK 1448207 T3 DK1448207 T3 DK 1448207T3 DK 02783334 T DK02783334 T DK 02783334T DK 02783334 T DK02783334 T DK 02783334T DK 1448207 T3 DK1448207 T3 DK 1448207T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical composition
dosage schedule
emergency contraception
contraception
emergency
Prior art date
Application number
DK02783334T
Other languages
Danish (da)
English (en)
Inventor
Look Paul F A Van
Illesne Balogh
Katalin Komandi
Laszlo Nemes
Zsolt Szabo
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Application granted granted Critical
Publication of DK1448207T3 publication Critical patent/DK1448207T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16Masculine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/18Drugs for disorders of the endocrine system of the parathyroid hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
DK02783334T 2001-11-27 2002-11-26 Doseringsplan og farmaceutisk sammensætning af nödprævention DK1448207T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HU0105173A HU227198B1 (en) 2001-11-27 2001-11-27 Pharmaceutical composition for emergency contraception containing levonorgestrel
EP02783334A EP1448207B1 (en) 2001-11-27 2002-11-26 Dosage regimen and pharmaceutical composition for emergency contraception
PCT/HU2002/000129 WO2003045397A1 (en) 2001-11-27 2002-11-26 Dosage regimen and pharmaceutical composition for emergency contraception

Publications (1)

Publication Number Publication Date
DK1448207T3 true DK1448207T3 (da) 2005-06-27

Family

ID=89998939

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02783334T DK1448207T3 (da) 2001-11-27 2002-11-26 Doseringsplan og farmaceutisk sammensætning af nödprævention

Country Status (33)

Country Link
US (1) US20050288264A2 (https=)
EP (1) EP1448207B1 (https=)
JP (1) JP2005516904A (https=)
KR (1) KR100908161B1 (https=)
CN (1) CN1551774A (https=)
AP (1) AP1849A (https=)
AT (1) ATE293978T1 (https=)
AU (1) AU2002347401A1 (https=)
BR (1) BR0210595A (https=)
CA (1) CA2450359C (https=)
DE (1) DE60203929T2 (https=)
DK (1) DK1448207T3 (https=)
EA (1) EA006545B1 (https=)
EC (1) ECSP045171A (https=)
ES (1) ES2239727T3 (https=)
GE (1) GEP20063882B (https=)
HR (1) HRP20040584B1 (https=)
HU (1) HU227198B1 (https=)
IL (1) IL159394A0 (https=)
IS (1) IS2691B (https=)
MA (1) MA27076A1 (https=)
MX (1) MXPA04005104A (https=)
NO (1) NO333984B1 (https=)
NZ (1) NZ530056A (https=)
OA (1) OA12730A (https=)
PL (1) PL206010B1 (https=)
PT (1) PT1448207E (https=)
RS (1) RS50768B (https=)
SI (1) SI1448207T1 (https=)
TN (1) TNSN04048A1 (https=)
UA (1) UA79942C2 (https=)
WO (1) WO2003045397A1 (https=)
ZA (1) ZA200404114B (https=)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008079245A2 (en) * 2006-12-20 2008-07-03 Duramed Pharmaceuticals, Inc. Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof
BRPI0819571A2 (pt) * 2007-12-20 2019-09-24 Teva Womenss Health Inc "método para contracepção de emergência, pacote farmacêutico para contracepção de emergência e composição farmacêutica"
US8512745B2 (en) 2008-12-08 2013-08-20 Laboratoire Hra Pharma Ulipristal acetate tablets
EP2365811A1 (en) * 2008-12-12 2011-09-21 Laboratoire HRA Pharma A method for contraception
BRPI1014035A2 (pt) 2009-04-14 2016-04-12 Hra Pharma Lab método para contracepção.
CN102458386B (zh) * 2009-06-23 2016-04-06 拜耳知识产权有限责任公司 用于紧急避孕的药物组合物
CN101732324B (zh) * 2009-12-31 2011-12-07 广州朗圣药业有限公司 一种含有左炔诺孕酮的紧急避孕药物组合物及其制备方法
SG195118A1 (en) 2011-06-01 2013-12-30 Estetra S A Process for the production of estetrol intermediates
PT2714712T (pt) 2011-06-01 2016-11-08 Estetra Sprl Processo para a produção de intermediários de estetrol
EP2383279A1 (en) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Process for the preparation of estetrol
PL2741824T3 (pl) * 2011-08-11 2018-03-30 Estetra S.P.R.L. Zastosowanie estetrolu jako środka antykoncepcji awaryjnej
CN104797258A (zh) 2012-11-22 2015-07-22 拜耳药业股份公司 包含左炔诺孕酮和cox抑制剂的药物组合物用于按需避孕的用途和施用方法
EP2999469A1 (de) 2013-05-23 2016-03-30 Bayer Pharma Aktiengesellschaft Pharmazeutische zusammensetzung und deren verwendung sowie anwendungsregime dieser pharmazeutischen zusammensetzung zur bedarfsweisen ( on-demand") kontrazeption
CN103877058A (zh) * 2014-03-26 2014-06-25 邵娜 一种左炔诺孕酮片及其制备工艺
LT3310345T (lt) 2015-06-18 2021-06-25 Estetra Sprl Burnoje disperguojama tabletė, turinti estetrolio
LT3310346T (lt) 2015-06-18 2021-06-10 Estetra Sprl Burnoje disperguojama tabletė, turinti estetrolio
DK3701944T3 (da) 2015-06-18 2022-03-14 Estetra Srl Oro-dispergerbar doseringsenhed indeholdende en estetrolkomponent
CR20180042A (es) 2015-06-18 2018-05-03 Mithra Pharmaceuticals S A Unidad de dosificación orodispersable que contiene un componente estetrol.
KR102712911B1 (ko) 2016-08-05 2024-10-04 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 월경통 및 생리통의 관리방법
CN111989105B (zh) 2018-04-19 2024-07-19 埃斯特拉私人有限责任公司 化合物以及它们在缓解绝经相关症状中的用途
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
CN110917154A (zh) * 2019-12-12 2020-03-27 上海信谊天平药业有限公司 一种左炔诺孕酮片的制备方法
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物
WO2022026901A2 (en) * 2020-07-30 2022-02-03 Acer Therapeutics Inc. Nk antagonists for contraception
CN119523923A (zh) * 2024-11-21 2025-02-28 华中药业股份有限公司 一种左炔诺孕酮片及其制备方法

Also Published As

Publication number Publication date
KR100908161B1 (ko) 2009-07-16
BR0210595A (pt) 2004-06-08
DE60203929D1 (de) 2005-06-02
RS50768B (sr) 2010-08-31
PL206010B1 (pl) 2010-06-30
PT1448207E (pt) 2005-08-31
IS2691B (is) 2010-10-15
HUP0105173A2 (hu) 2003-08-28
MXPA04005104A (es) 2004-08-19
CA2450359A1 (en) 2003-06-05
HUP0105173D0 (en) 2002-02-28
EP1448207A1 (en) 2004-08-25
AU2002347401A1 (en) 2003-06-10
US20050288264A2 (en) 2005-12-29
NZ530056A (en) 2005-02-25
ECSP045171A (es) 2004-08-27
DE60203929T2 (de) 2006-01-19
EA200400731A1 (ru) 2004-12-30
JP2005516904A (ja) 2005-06-09
EP1448207B1 (en) 2005-04-27
RS4204A (sr) 2007-02-05
IS7065A (is) 2003-12-05
CA2450359C (en) 2011-05-10
HU227198B1 (en) 2010-10-28
TNSN04048A1 (en) 2006-06-01
AP2004003046A0 (en) 2004-06-30
WO2003045397A1 (en) 2003-06-05
PL369520A1 (en) 2005-04-18
IL159394A0 (en) 2004-06-01
EA006545B1 (ru) 2006-02-24
ZA200404114B (en) 2005-10-26
HUP0105173A3 (en) 2004-03-29
GEP20063882B (en) 2006-07-25
AP1849A (en) 2008-05-23
CN1551774A (zh) 2004-12-01
UA79942C2 (en) 2007-08-10
ATE293978T1 (de) 2005-05-15
HRP20040584A2 (en) 2005-02-28
ES2239727T3 (es) 2005-10-01
HRP20040584B1 (en) 2012-11-30
SI1448207T1 (en) 2005-10-31
NO333984B1 (no) 2013-11-04
OA12730A (fr) 2006-06-28
MA27076A1 (fr) 2004-12-20
NO20041607L (no) 2004-04-20
US20050032755A1 (en) 2005-02-10
KR20040066088A (ko) 2004-07-23

Similar Documents

Publication Publication Date Title
DK1448207T3 (da) Doseringsplan og farmaceutisk sammensætning af nödprævention
DK1562556T3 (da) Farmaceutiske sammensætninger og doseringsformer af thalidomid
ATE296619T1 (de) Feste orale dosierungsform von simethicon
BRPI0209720A2 (pt) dosagem e embalagem de medicação com liberação controlada
DE60121992D1 (de) Zusammensetzung zur verabreichung und beschichtung medizinischer geräte
DK1478339T3 (da) Farmaceutiske formuleringer af antineoplastiske midler, specielt temozolomid, fremgangsmåder til fremstilling og anvendelse heraf
DK1158992T3 (da) Anvendelse af xenon til fremstilling af et farmaceutisk præparat til behandling af neurointoksikationer
FI20011478A0 (fi) Farmaseuttinen koostumus
PT1207867E (pt) Formas de administracao farmaceuticas orais retardadas contendo tramadol
PL368519A1 (pl) Kompozycje farmaceutyczne amlodypiny i atorwastatyny
HUP0401656A3 (en) Mch antagonists for the treatment of obesity and pharmaceutical compositions containing them
DK1537096T3 (da) Derivater af dioxan-2-alkylcarbamater, fremstilling og terapeutisk anvendelse heraf
DK1949936T3 (da) Sammensætning til kontrolleret frigivelse og fremgangsmåde til fremstilling deraf
NO20033123L (no) Terapeutisk hinne dannende sammensetning og behandlingsplan derav
GB0108470D0 (en) Pharmaceutical compositions and their use
FI20022128L (fi) Farmaseuttinen koostumus
DK2017269T3 (da) Krystallinsk form II af ritonavirindeholdende farmaceutisk sammensætning og fremstilling heraf
PL361518A1 (pl) Zastosowanie substancji oraz kompozycja farmaceutyczna
DE60329614D1 (de) Polymerzusammensetzung sowie diese enthaltende darreichungsformen
DE60232445D1 (de) Cetirizin und pseudoephedrin enthaltende tablette
EE200300468A (et) Pravastatiini stabiilne farmatseutiline kompositsioon
NO20034172L (no) Bisykliske guanidinderivater og terapeutiske anvendelser derav
DK1385513T3 (da) Farmaceutiske kombinationer af pyridoindollonderivater og anticancermidler
DK1406591T3 (da) Farmaceutisk sammensætning til nasal tilförsel af estradiol og norethisteron
EP1413314A4 (en) MEDICAL COMPOSITIONS